'Real-life experience': Recurrence rate at 3 years with Hexvix photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC- A prospective controlled study
World Journal of Urology Aug 16, 2017
Gallagher KM, et al. – The physicians conducted this work to compare the recurrence rate at 3 years (RR–3y) for non–muscle invasive bladder cancer (NMIBC) between good quality (GQ) PDD–TURBT and GQWL–TURBT where PDD is applied in routine practice for all new tumours. It was concluded that PDD appears to be correlated with significantly reduced recurrence rates at 3 years in the Âreal life experience, particularly in high–risk patients when adopted for all new bladder tumour resections in routine practice.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries